Fluconazole distribution to the brain: A crossover study in freely-moving rats using in vivo microdialysis

Pharmaceutical Research

Volumn 13, Issue 10, 1996, Pages 1570-1575

  Yang, Hua ^a   Wang, Qin ^a   Elmquist, William F ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Brain distribution; Fluconazole; Microdialysis; Pharmacokinetics

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ANIMAL EXPERIMENT; ARTICLE; DRUG BRAIN LEVEL; DRUG DISTRIBUTION; DRUG TISSUE LEVEL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MICRODIALYSIS; NONHUMAN; PHARMACOKINETICS; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIFUNGAL AGENTS; BLOOD-BRAIN BARRIER; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FEASIBILITY STUDIES; FLUCONAZOLE; INJECTIONS, INTRAVENOUS; MALE; MICRODIALYSIS; RATS; RATS, SPRAGUE-DAWLEY; SPECTROPHOTOMETRY, ULTRAVIOLET; TISSUE DISTRIBUTION; TRIAZOLES;

EID: 0029910856     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016048100712     Document Type: Article

References (26)

1. G. Foulds, D. R. Brennan, C. Wajszczuk, A. Catanzaro, D. C. Garg, W. Knopf, M. Rinaldi, and D. J. Weidler. J. Clin. Pharmacol. 28:363-366 (1988).
2. G. P. Bodey. Clin. Infect. Dis. 14:s161-169.
3. P. D. Hoeprich, J. L. Ingraham, E. Kleker, and M. J. Winship. J. Infect. Dis. 130:112-118 (1974).
4. S. Normark and J. Schonebeck. Antimicrob. Agents Chemother. 2:144-121 (1972).
5. S. G. Jezequel. J. Pharm. Pharmacol. 6:196-199 (1994).
6. A. J. Berry, M. G. Rinaldi, and J. R. Graybill. Antimicrob. Agents Chemother. 36:690-692 (1992).
7. R. M. Tucker, J. N. Galgiani, D. W. Denning, L. H. Hanson, J. R. Graybill, K. Sharkey, M. R. Eckman, C. Salemi, R. Libke, R. A. Klein, and D. A. Stevens. Rev. Infect. Dis. 12:S380-S389 (1990).
8. R. Allendoerfer, A. J. Marquis, M. G. Rinaldi, and J. R. Graybill. Antimicrob. Agents Chemother. 35:726-729 (1991).
9. F. C. Odds, S. L. Cheesman, and A. B. Abbott. J. Antimicrob. Chemother. 18:473-478 (1986).
10. E. M. Bailey, D. J. Krakovsky, and M. J. Rybak. Pharmacotherapy 10:146-153 (1990).
11. R. H. Haubrich, D. Haghighat, S. A. Bozzette, J. Tilles, J. A. McCutchan, and the California Collaborative Treatment Group. J. Infect. Dis. 170:238-242 (1994).
12. E. J. Anaissie, D. P. Kontoyiannis, C. Huls, S. E. Vartivarian, C. Karl, R. A. Prince, J. Bosso, and G. P. J. Infect. Dis. 172:599-602 (1995).
13. B. K. Malhotra, M. Lemaire, and R. J. Sawchuk. Pharm. Res. 11:1223-1232 (1994).
14. Q. Wang, H. Yang, D. W. Miller, and W. F. Elmquist. Biochem. Biophys. Res. Commun. 211:719-726 (1995).
15. K. H. Dykstra, A. Arya, D. M. Arriola, P. M. Bungay, P. F. Morrison and R. L. Dedrick. J. Pharmacol. Exp. Ther. 267:1227-1236 (1993).
16. C. M. Ervine and J. B. Houston. Pharm. Res. 11:961-965 (1994).
17. M. J. Humphrey, S. Jevons, and M. H. Tarbit. Antimicrob. Agents Chemother. 28:648-653 (1985).
18. R. A. Yokel, D. D. Allen, D. E. Burgio, and P. J. McNanara. J. Pharmacol. Toxicol. Meth. 27:135-142 (1992).
19. L. Stahle, S. Segersvard, and U. Ungerstedt. J. Pharmacol. Meth. 25:41-52 (1991).
20. Y. Wang, S. L. Wong, and R. J. Sawchuk. Pharm. Res. 10:1411-1419 (1993).
21. I. Westergren, B. Nystrom, A. Hamberger, and B. B. Johansson. J. Neurochem. 64:229-234 (1995).
22. M. E. Morgan, D. Singhal, and B. D. Anderson. J. Pharmacol. Exper. Ther. 277:1167-1176 (1996).
23. M. Fontaine, Q. Wang, H. Yang, and W. F. Elmquist. Pharm. Res. 12:S-406 (1995).
24. J. R. Perfect and D. T. Durack. J. Antimicrob. Chemother. 16:81-86 (1985).
25. C. A. S. Arndt, T. J. Walsh, C. L. McCully, F. M. Balis, P. A. Pizzo, and D. G. Poplack. J. Infect. Dis. 157:178-180 (1988).
26. F. Thaler, B. Bernard, M. Tod, C. P. Jedynak, O. Petitjean, P. Derome and P. Loirat. Antimicrob. Agents Chemother. 39:1154-1156 (1995).